FDA Assails AstraZeneca's Attack On Crestor Generics
The U.S. Food and Drug Administration urged a D.C. federal court Tuesday to toss an AstraZeneca suit aimed at blocking Crestor generics, labeling it a "transparent and manifestly premature attempt" to...To view the full article, register now.
Already a subscriber? Click here to view full article